Literature DB >> 20016474

The influence of TSLP on the allergic response.

M R Comeau1, S F Ziegler.   

Abstract

Exposure to allergens first occurs at body surfaces in direct contact with the environment such as the skin, airways, and gastrointestinal tract, and compelling evidence suggests that allergic inflammatory responses are profoundly influenced by the products of epithelial cells located at these sites. One such product is thymic stromal lymphopoietin (TSLP), which is capable of affecting multiple cell lineages involved in allergic reactions. In this review we discuss recent work that has provided insight into the role TSLP plays in both aberrant and protective allergic inflammatory responses, as well as regulation, associations with disease, sources, and functions of this important cytokine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20016474     DOI: 10.1038/mi.2009.134

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  46 in total

1.  Exacerbation of allergen-induced eczema in TLR4- and TRIF-deficient mice.

Authors:  Eric B Brandt; Aaron M Gibson; Stacey Bass; Carolyn Rydyznski; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

Review 2.  Immunopathology of chronic rhinosinusitis.

Authors:  Atsushi Kato
Journal:  Allergol Int       Date:  2015-02-09       Impact factor: 5.836

Review 3.  The regulation of thymic stromal lymphopoietin in gut immune homeostasis.

Authors:  Ming Li; Ji Zhang; Yuzhang Wu; Jintao Li
Journal:  Dig Dis Sci       Date:  2011-02-12       Impact factor: 3.199

Review 4.  TSLP Inhibitors for Asthma: Current Status and Future Prospects.

Authors:  Maria Gabriella Matera; Paola Rogliani; Luigino Calzetta; Mario Cazzola
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

Review 5.  Sentinels at the wall: epithelial-derived cytokines serve as triggers of upper airway type 2 inflammation.

Authors:  Neil N Patel; Michael A Kohanski; Ivy W Maina; Alan D Workman; De'Broski R Herbert; Noam A Cohen
Journal:  Int Forum Allergy Rhinol       Date:  2018-09-10       Impact factor: 3.858

Review 6.  Pediatric Eosinophilic Esophagitis Endotypes: Are We Closer to Predicting Treatment Response?

Authors:  Anna E Ferguson; Vince A Mukkada; Patricia C Fulkerson
Journal:  Clin Rev Allergy Immunol       Date:  2018-08       Impact factor: 8.667

7.  Proprotein convertases generate a highly functional heterodimeric form of thymic stromal lymphopoietin in humans.

Authors:  Julie A Poposki; Aiko I Klingler; Whitney W Stevens; Anju T Peters; Kathryn E Hulse; Leslie C Grammer; Robert P Schleimer; Kevin C Welch; Stephanie S Smith; Douglas M Sidle; David B Conley; Bruce K Tan; Robert C Kern; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2016-10-12       Impact factor: 10.793

8.  Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis.

Authors:  Rana Herro; Ricardo Da Silva Antunes; Amelia Roman Aguilera; Koji Tamada; Michael Croft
Journal:  J Allergy Clin Immunol       Date:  2015-02-11       Impact factor: 10.793

9.  The control of tissue fibrosis by the inflammatory molecule LIGHT (TNF Superfamily member 14).

Authors:  Rana Herro; Michael Croft
Journal:  Pharmacol Res       Date:  2015-12-31       Impact factor: 7.658

10.  Thymic stromal lymphopoietin is up-regulated in the skin of patients with systemic sclerosis and induces profibrotic genes and intracellular signaling that overlap with those induced by interleukin-13 and transforming growth factor β.

Authors:  Romy B Christmann; Allison Mathes; Alsya J Affandi; Cristina Padilla; Banafsheh Nazari; Andreea M Bujor; Giuseppina Stifano; Robert Lafyatis
Journal:  Arthritis Rheum       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.